Outlook for Overall Expansion of the Medical Device Market
First written in FY2016-Q3. 16 of 27 entries say "Restated". Latest entry: FY2025.
Mani moved to the "Worse" side of this theme in 2022.
0 other companies' latest entry also says "Reframed".
- FY2025ReframedAnnual report
「The medical device market targeted by our Group is expected to see rising global demand for products, supported not only by continued market growth but also by the increasing use of minimally invasive treatments and ongoing technological innovation. At the same time, competition is intensifying because of policies favoring domestically produced goods in emerging economies and cost competition from companies in those markets.」
The market outlook has been refined to cite rising demand driven by minimally invasive treatment and technological innovation, alongside intensifying competition from domestic-preference policies and cost competition in emerging markets. - FY2024RestatedAnnual report
「At the same time, market activity is expected to benefit from greater awareness of infection prevention, while demand in emerging markets is expected to grow as healthcare infrastructure improves and incomes rise. Overall, we continue to expect the medical device market to expand.」
The statement cites greater awareness of infection prevention and improving healthcare infrastructure and incomes in emerging markets as drivers of continued expansion of the overall medical device market. - FY2024-Q3ReframedAnnual report
「Although the healthcare and medical device industries in which our Group operates are affected by these external conditions, expectations for high-quality healthcare are rising worldwide as society ages and IT technology advances. Over the medium to long term, this is expected to create more business opportunities while intensifying competition.」
The statement identifies population aging, advances in IT and rising global expectations for high-quality healthcare as additional sources of business opportunities, while also noting intensifying competition. - FY2024-Q2ReframedAnnual report
「Although the healthcare and medical device industries are affected by these external conditions, the aging of the population and growing expectations for improved quality of life are expected to create more business opportunities and intensify competition over the medium to long term.」
The outlook adds greater medium- to long-term business opportunities arising from population aging and expectations for improved quality of life, while also noting intensifying competition. - FY2023RestatedAnnual report
「At the same time, market activity is expected to benefit from greater awareness of infection prevention, while demand in emerging markets is expected to grow as healthcare infrastructure improves and incomes rise. Overall, we continue to expect the medical device market to expand.」
The statement reaffirms the expected expansion of the overall medical device market, citing greater awareness of infection prevention and improving healthcare infrastructure and incomes in emerging markets. - FY2023-Q3ReframedAnnual report
「Compared with the same period of the previous year, which was affected by COVID-19, product demand increased mainly in Asia, Europe and South America」
South America has been added to Asia and Europe as a region where product demand has increased, indicating recovery and growth from the COVID-19-affected year-earlier period. - FY2023-Q2RestatedAnnual report
「Compared with the same period of the previous year, which was affected by COVID-19, product demand increased mainly in Japan, Asia and Europe」
The statement continues to indicate stronger product demand mainly in Japan, Asia and Europe compared with the COVID-19-affected year-earlier period. - FY2023-Q1ReframedAnnual report
「Compared with the same period of the previous year, which was affected by COVID-19, product demand increased mainly in Japan, Europe and Asia」
The business environment has shifted from COVID-19-related demand declines to stronger demand mainly in Japan, Europe and Asia, while uncertainty from higher raw material and energy prices, inflation and foreign-exchange movements is also noted. - FY2022-Q3ReframedAnnual report
「During the first nine months of the current fiscal year, the global economy was recovering as COVID-19-related restrictions were eased except in some regions. However, the outlook remains uncertain because of global supply-chain disruption, higher resource prices resulting from Russia’s invasion of Ukraine, the sharp depreciation of the yen, and mounting inflationary pressure.」
The statement cites recovery following the easing of COVID-19 restrictions, while adding supply-chain disruption, higher resource prices, the sharp depreciation of the yen, and inflationary pressure as sources of uncertainty. - FY2022-Q1ReframedAnnual report
「During the first quarter of the current fiscal year, the global economy was recovering as restrictions were gradually eased in countries following the rollout of COVID-19 vaccines. However, supply was frequently unable to keep pace with demand as economies recovered, resulting in higher raw material prices and freight rates and disruptions to supply chains. Concern has also grown recently over a renewed spread of COVID-19 caused by new variants, leaving the outlook uncertain.」
The statement shifts to describing a recovering global economy supported by vaccination and eased restrictions, while citing supply constraints, higher raw material and freight costs, supply-chain disruptions, and concern over new variants. - FY2021ReframedAnnual report
「At the same time, over the medium to long term, the recovery of socioeconomic activity is expected to accelerate as vaccination rates rise. Greater awareness of infection prevention is also expected to promote the use of disposable products, while demand in emerging markets is expected to grow as healthcare infrastructure improves and incomes rise.」
In addition to the established outlook for demand growth in emerging markets, the statement identifies socioeconomic recovery following vaccination and greater use of disposable products as medium- to long-term growth drivers. - FY2021-Q3RestatedAnnual report
「Primarily in emerging markets, where demand is expected to expand」
The outlook continues to indicate expanding demand in emerging-country markets. - FY2020ReframedAnnual report
「Meanwhile, the global spread of COVID-19 has constrained economic activity worldwide, and the strain on healthcare systems is expected to temporarily reduce the number of surgical procedures and other medical treatments. We therefore expect challenging conditions to continue. Over the medium to long term, however, demand is expected to expand as infection prevention drives greater use of disposable products and new technologies and products broaden the range of surgical indications. Demand is also expected to grow in emerging markets as healthcare infrastructure improves and incomes rise.」
The outlook adds a short-term decline in surgeries caused by COVID-19 to the existing growth outlook based on disposable products, new technologies and emerging-market demand. - FY2020-Q2RestatedAnnual report
「In emerging-country markets, where demand is expected to continue expanding」
The outlook continues to indicate expanding demand in emerging-country markets. - FY2020-Q1RestatedAnnual report
「In emerging-country markets, where demand is expected to continue expanding」
The outlook continues to indicate expanding demand in emerging-country markets. - FY2019ReframedAnnual report
「Demand is also expected to expand as infection prevention drives greater use of disposable products and new technologies and products broaden the range of surgical indications. In emerging markets, demand is also expected to grow as healthcare infrastructure improves and incomes rise.」
The market expansion drivers identified include greater use of disposable products, broader surgical indications resulting from new technologies and products, and rising demand in emerging markets as healthcare infrastructure and incomes improve. - FY2019-Q3RestatedAnnual report
「In emerging-country markets, where demand is expected to continue expanding」
The outlook continues to indicate expanding demand in emerging-country markets. - FY2018RestatedAnnual report
「In the medical device industry, developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards. However, the adoption of advanced medical care is progressing, while medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites the challenging environment in developed countries alongside growing demand in emerging countries, reaffirming the expected expansion of the overall medical device market. - FY2018-Q3RestatedAnnual report
「In Japan, the healthcare market is expected to expand as the population ages and advanced medical care is adopted. At the same time, healthcare policies aimed at restraining overall growth in healthcare spending continue against the backdrop of worsening national and public health insurance finances. Overseas, developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards. However, medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites expansion of Japan's healthcare market and policies to contain healthcare spending, as well as the challenging environment in developed countries and growing demand in emerging countries, reaffirming the expected expansion of the overall market. - FY2018-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, the environment surrounding our Group in Japan included expectations for expansion of the healthcare market due to population aging and the adoption of advanced medical care. At the same time, healthcare policies aimed at restraining overall growth in healthcare spending continued against the backdrop of worsening national and public health insurance finances. Overseas, developed countries continued to face challenging conditions, including policies to contain healthcare spending and tighter approval standards. However, medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
In Japan, the expected expansion of the healthcare market and continuing policies to contain healthcare spending are presented together. Overseas, the challenging environment in developed countries is cited alongside growing demand in emerging countries, reaffirming the expected expansion of the overall market. - FY2018-Q1RestatedAnnual report
「Although developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards, the adoption of advanced medical care is progressing. In emerging countries, medical infrastructure is being developed alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites the challenging environment in developed countries alongside growing demand in emerging countries, reaffirming the expected expansion of the overall medical device market. - FY2017RestatedAnnual report
「Although developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards, the adoption of advanced medical care is progressing. In emerging countries, medical infrastructure is being developed alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites the factors restraining developed-country markets alongside growing demand for healthcare in emerging countries, reaffirming the expected expansion of the overall medical device market. - FY2017-Q3RestatedAnnual report
「During the third quarter of the current consolidated cumulative period, the medical device industry continued to face challenging conditions in developed countries, including policies to contain healthcare spending and tighter approval standards. However, the adoption of advanced medical care is progressing, while medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook continues to indicate expansion of the overall medical device market, citing the challenging environment in developed countries and growing demand in emerging countries. - FY2017-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, the medical device industry continued to face challenging conditions in developed countries, including policies to contain healthcare spending and tighter approval standards. However, the adoption of advanced medical care is progressing, while medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook continues to indicate expansion of the overall medical device market, citing the challenging environment in developed countries and growing demand in emerging countries. - FY2017-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, the medical device industry continued to face challenging conditions in developed countries, including policies to contain healthcare spending and tighter approval standards. However, the adoption of advanced medical care is progressing, while medical infrastructure is being developed in emerging countries alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites the challenging environment in developed countries alongside growing demand in emerging countries, reaffirming the expected expansion of the overall medical device market. - FY2016RestatedAnnual report
「Although developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards, the adoption of advanced medical care is progressing. In emerging countries, medical infrastructure is being developed alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook again cites the factors restraining developed-country markets alongside growing demand in emerging countries, reaffirming the expected expansion of the overall medical device market. - FY2016-Q3First statedAnnual report
「Although developed countries continue to face challenging conditions, including policies to contain healthcare spending and tighter approval standards, the adoption of advanced medical care is progressing. In emerging countries, medical infrastructure is being developed alongside population growth and economic development. Accordingly, we expect the market as a whole to continue expanding.」
The outlook indicates that the overall medical device market will expand, while noting the challenging environment in developed countries and growing demand in emerging countries.